Thank you for your continued support of KAIAN and EVOLURE.
We are pleased to announce that, as of June 2026, the business previously operated under the trade name "KAIAN" has been formally incorporated as KAIAN Inc.
Why we incorporated
Under the mission of "Creating the future of skin with Beauty × Technology," KAIAN has been developing the skincare brand EVOLURE and researching AI skin diagnosis systems. Through incorporation, we are establishing a more sustainable and accountable operating structure to accelerate our work toward Skin Longevity.
Message from the founder
In the cosmetics industry, we have long observed structural challenges: opacity of effects, information asymmetry, and one-size-fits-all care. Our answers are: ingredient transparency, data-driven personalization, and education-first communication.
EVOLURE is not merely a cosmetics brand; it is a next-generation skincare system that fuses skin science with AI. By leveraging the trust and agility that incorporation brings, we will continue to be a long-term partner for every customer's skin.
KAIAN Inc.
Representative Director, CEO Shigeki Hosono
Company Overview
| Company Name | KAIAN Inc. |
|---|---|
| Representative | Representative Director, CEO Shigeki Hosono |
| Founded | June 2026 |
| Capital | JPY 5,000,000 |
| Fiscal Year | June – May |
| Location | 155-0031 1-38-14 Kitazawa, Setagaya-ku, Tokyo (Showa Shimokita Bldg. 2F) |
| Business | Planning, development and sales of skincare brand "EVOLURE" Development and operation of AI skin diagnosis system |
| URL | https://kaian.jp |
Looking ahead
We will continue to improve the accuracy of our AI skin diagnosis system, expand the EVOLURE product lineup, and deliver evidence-based skincare knowledge through our "Skincare University" content series.
As we approach the launch of EVOLURE on July 20, 2026, every member of our team will work harder than ever. We sincerely appreciate your continued support.
Media Inquiries
Please contact us via the Contact Form.